Bibliography
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Ã ., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., Yang, Q., Bishop, J. M., Contag, C. H., & Felsher, D. W. (2004). MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature, 431(7012), 1112â1117.
Authors
14
- Catherine M. Shachaf (first)
- Andrew M. Kopelman (additional)
- Constadina Arvanitis (additional)
- Åsa Karlsson (additional)
- Shelly Beer (additional)
- Stefanie Mandl (additional)
- Michael H. Bachmann (additional)
- Alexander D. Borowsky (additional)
- Boris Ruebner (additional)
- Robert D. Cardiff (additional)
- Qiwei Yang (additional)
- J. Michael Bishop (additional)
- Christopher H. Contag (additional)
- Dean W. Felsher (additional)
References
30
Referenced
731
-
Nowak, A. K., Chow, P. K. & Findlay, M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur. J. Cancer 40, 1474–1484 (2004)
(
10.1016/j.ejca.2004.02.027
) / Eur. J. Cancer by AK Nowak (2004) -
Bishop, J. M. Molecular themes in oncogenesis. Cell 64, 235–248 (1991)
(
10.1016/0092-8674(91)90636-D
) / Cell by JM Bishop (1991) -
Felsher, D. W. Cancer revoked: oncogenes as therapeutic targets. Nature Rev. Cancer 3, 375–380 (2003)
(
10.1038/nrc1070
) / Nature Rev. Cancer by DW Felsher (2003) -
Jain, M. et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102–104 (2002)
(
10.1126/science.1071489
) / Science by M Jain (2002) -
Coleman, W. B. Mechanisms of human hepatocarcinogenesis. Curr. Mol. Med. 3, 573–588 (2003)
(
10.2174/1566524033479546
) / Curr. Mol. Med. by WB Coleman (2003) - Sandgren, E. P., Quaife, C. J., Pinkert, C. A., Palmiter, R. D. & Brinster, R. L. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4, 715–724 (1989) / Oncogene by EP Sandgren (1989)
- Murakami, H. et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. 53, 1719–1723 (1993) / Cancer Res. by H Murakami (1993)
-
Wu, Y. et al. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. Oncogene 21, 1518–1526 (2002)
(
10.1038/sj.onc.1205208
) / Oncogene by Y Wu (2002) -
Simile, M. M. et al. Downregulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25, 333–334 (2003)
(
10.1093/carcin/bgh014
) / Carcinogenesis by MM Simile (2003) -
Kistner, A. et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl Acad. Sci. USA 93, 10933–10938 (1996)
(
10.1073/pnas.93.20.10933
) / Proc. Natl Acad. Sci. USA by A Kistner (1996) -
Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199–207 (1999)
(
10.1016/S1097-2765(00)80367-6
) / Mol. Cell by DW Felsher (1999) -
Venook, A. P. Hepatocellular carcinoma. Curr. Treat. Options Oncol. 1, 407–415 (2000)
(
10.1007/s11864-000-0068-z
) / Curr. Treat. Options Oncol. by AP Venook (2000) -
Thorgeirsson, S. S. Hepatic stem cells in liver regeneration. FASEB J. 10, 1249–1256 (1996)
(
10.1096/fasebj.10.11.8836038
) / FASEB J. by SS Thorgeirsson (1996) -
Fausto, N. Hepatocyte differentiation and liver progenitor cells. Curr. Opin. Cell Biol. 2, 1036–1042 (1990)
(
10.1016/0955-0674(90)90153-6
) / Curr. Opin. Cell Biol. by N Fausto (1990) -
Fausto, N. & Campbell, J. S. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117–130 (2003)
(
10.1016/S0925-4773(02)00338-6
) / Mech. Dev. by N Fausto (2003) -
Hardy, J. et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol. 29, 1353–1360 (2001)
(
10.1016/S0301-472X(01)00756-1
) / Exp. Hematol. by J Hardy (2001) - Uhr, J. W., Tucker, T., May, R. D., Siu, H. & Vitetta, E. S. Cancer dormancy: studies of the murine BCL1 lymphoma. Cancer Res. 51, 5045s–5053s (1991) / Cancer Res. by JW Uhr (1991)
-
Demicheli, R. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin. Cancer Biol. 11, 297–306 (2001)
(
10.1006/scbi.2001.0385
) / Semin. Cancer Biol. by R Demicheli (2001) -
Naumov, G. N., MacDonald, I. C., Chambers, A. F. & Groom, A. C. Solitary cancer cells as a possible source of tumour dormancy? Semin. Cancer Biol. 11, 271–276 (2001)
(
10.1006/scbi.2001.0382
) / Semin. Cancer Biol. by GN Naumov (2001) -
Uhr, J. W., Scheuermann, R. H., Street, N. E. & Vitetta, E. S. Cancer dormancy: opportunities for new therapeutic approaches. Nature Med. 3, 505–509 (1997)
(
10.1038/nm0597-505
) / Nature Med. by JW Uhr (1997) -
Riethmuller, G. & Klein, C. A. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin. Cancer Biol. 11, 307–311 (2001)
(
10.1006/scbi.2001.0386
) / Semin. Cancer Biol. by G Riethmuller (2001) -
Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149–153 (1995)
(
10.1038/nm0295-149
) / Nature Med. by L Holmgren (1995) -
Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer and cancer stem cells. Nature 414, 105–111 (2001)
(
10.1038/35102167
) / Nature by T Reya (2001) -
Willert, K. et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423, 448–452 (2003)
(
10.1038/nature01611
) / Nature by K Willert (2003) -
Al-Hajj, M. B., Wicha, M. W., Weissman, M. & Clarke, I. M. F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14, 43–47 (2004)
(
10.1016/j.gde.2003.11.007
) / Curr. Opin. Genet. Dev. by MB Al-Hajj (2004) -
Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197–205 (1995)
(
10.1016/0092-8674(95)90329-1
) / Cell by PW Laird (1995) -
Lotem, J. & Sachs, L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin. Cancer Biol. 12, 339–346 (2002)
(
10.1016/S1044-579X(02)00054-8
) / Semin. Cancer Biol. by J Lotem (2002) - Leffert, K. S. & Skelly, K. in Cell Culture Methods for Molecular and Cell Biology (eds Barnes, D. W., Sirbasku, D. A. & Sato, G. H.) 43–55 (Alan R. Liss, New York, 1984)
-
Edinger, M. et al. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101, 640–648 (2003)
(
10.1182/blood-2002-06-1751
) / Blood by M Edinger (2003) -
Pollack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23, 41–46 (1999)
(
10.1038/14385
) / Nature Genet. by JR Pollack (1999)
Dates
Type | When |
---|---|
Created | 20 years, 10 months ago (Oct. 10, 2004, 12:58 p.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 2:28 p.m.) |
Indexed | 1 day, 3 hours ago (Aug. 26, 2025, 2:51 a.m.) |
Issued | 20 years, 10 months ago (Oct. 1, 2004) |
Published | 20 years, 10 months ago (Oct. 1, 2004) |
Published Online | 20 years, 10 months ago (Oct. 10, 2004) |
Published Print | 20 years, 10 months ago (Oct. 1, 2004) |
@article{Shachaf_2004, title={MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer}, volume={431}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature03043}, DOI={10.1038/nature03043}, number={7012}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Shachaf, Catherine M. and Kopelman, Andrew M. and Arvanitis, Constadina and Karlsson, Åsa and Beer, Shelly and Mandl, Stefanie and Bachmann, Michael H. and Borowsky, Alexander D. and Ruebner, Boris and Cardiff, Robert D. and Yang, Qiwei and Bishop, J. Michael and Contag, Christopher H. and Felsher, Dean W.}, year={2004}, month=oct, pages={1112–1117} }